As active pharmaceutical ingredients (APIs) and medicines become more complex and the demand for efficiency rises, drug ...
The big pharma company Sanofi has discontinued a phase 2 trial of U.S. partner Denali Therapeutics’ oditrasertib for the ...
From exploring the wonders of plants as a curious teen to leading global initiatives at SCIEX, Gitte Barknowitz has carved ...
Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization ...
The big pharma company AstraZeneca has forged a licensing pact worth $2 billion with the Chinese firm CSPC Pharmaceutical ...
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer ...
But what does the Act mean for the biotech and pharma industry and how can companies best prepare for any impacts on future business? The Biosecure Act was first proposed by the US government late ...
Months after divesting seven European sites, the Swedish contract development and manufacturing organisation (CDMO) Recipharm is expanding its manufacturing capacity with undisclosed investments in ...
Artificial intelligence (AI) is now infiltrating core industries and according to Forbes, the market is expected to reach a value of $22.6 billion dollars by next year (2025). One area it is thriving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback